RBC Europe’s Quest Diagnostics DGX Stock Holding History

RBC Europe’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$265K	Hold	1,993	–	–	0.01%	181
2022 Q1	$273K	Hold	1,993	–	–	0.01%	196
2021 Q4	$345K	Hold	1,993	–	–	0.02%	178
2021 Q3	$290K	Buy	1,993 +79	+4%	+$11.6K	0.01%	258
2021 Q2	$253K	Hold	1,914	–	–	0.01%	284
2021 Q1	$246K	Hold	1,914	–	–	0.01%	266
2020 Q4	$228K	Sell	1,914 -60	-3%	-$7.31K	0.01%	264
2020 Q3	$226K	Hold	1,974	–	–	0.02%	239
2020 Q2	$225K	Sell	1,974 -100	-5%	-$10.6K	0.02%	222
2020 Q1	$167K	Hold	2,074	–	–	0.02%	234
2019 Q4	$221K	Hold	2,074	–	–	0.02%	240
2019 Q3	$222K	Hold	2,074	–	–	0.02%	234
2019 Q2	$211K	Buy	2,074 +50	+2%	+$4.8K	0.02%	245
2019 Q1	$182K	Buy	2,024 +50	+3%	+$4.33K	0.02%	248
2018 Q4	$164K	Hold	1,974	–	–	0.02%	244
2018 Q3	$213K	Hold	1,974	–	–	0.02%	239
2018 Q2	$217K	Hold	1,974	–	–	0.03%	235
2018 Q1	$198K	Hold	1,974	–	–	0.02%	243
2017 Q4	$194K	Sell	1,974 -50	-2%	-$4.74K	0.02%	252
2017 Q3	$190K	Buy	+2,024	New	+$215K	0.02%	253

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

RBC Europe's DGX Position: Q2 2022 in Review

RBC Europe held its Quest Diagnostics (DGX) position steady in Q2 2022 at 1,993 shares worth $265K. The position accounts for 0.01% of the portfolio, ranked #181.

RBC Europe first reported a position in DGX in Q3 2017 and has held it in 20 quarters since. The position peaked at $345K in Q4 2021. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

RBC Europe held 1,993 shares of Quest Diagnostics worth $265K as of Q2 2022.
RBC Europe left its Quest Diagnostics share count unchanged in Q2 2022.
Quest Diagnostics made up 0.01% of RBC Europe's portfolio in Q2 2022, its #181 holding.
RBC Europe first reported a position in Quest Diagnostics in Q3 2017 and has held it in 20 quarters since.
RBC Europe's Quest Diagnostics position peaked at $345K in Q4 2021.
850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.